# Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

> **NCT00994617** · PHASE4 · UNKNOWN · sponsor: **University of Cambridge** · enrollment: 600 (estimated)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy
- Essential Hypertension

## Interventions

- **DRUG:** Losartan and hydrochlorothiazide
- **DRUG:** Hydrochlorothiazide switched over with Losartan at 8 weeks

## Key facts

- **NCT ID:** NCT00994617
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2013-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994617, "Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00994617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*